z-logo
open-access-imgOpen Access
Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study
Author(s) -
Sm Gowri Vishalashi,
Poonam Gupta,
Priyanka Verma
Publication year - 2021
Publication title -
indian journal of critical care medicine/indian journal of critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 30
eISSN - 1998-359X
pISSN - 0972-5229
DOI - 10.5005/jp-journals-10071-23802
Subject(s) - procalcitonin , medicine , sepsis , septic shock , intensive care unit , antibiotics , antibiotic therapy , biomarker , prospective cohort study , biochemistry , chemistry , microbiology and biotechnology , biology
Procalcitonin, a biomarker to adjudge the duration of antibiotic therapy in patients with sepsis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here